SCHEMBL16775447

SCHEMBL16775447

CC(F)(F)c1cccc(-n2ccc(-c3cccc(C(=O)O)c3)c2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
RXRA P19793 4/20 0.48
RXRB P28702 3/20 0.48
KMO O15229 1/20 0.46
COMT P21964 1/20 0.40
DHODH Q02127 2/20 0.39
GRIN1 Q05586 1/20 0.39
GRIN2B Q13224 1/20 0.39
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
PKM P14618 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
STIM1 Q13586 1/20 0.38
ORAI1 Q96D31 1/20 0.38
USP2 O75604 1/20 0.38
MYC P01106 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2712235 0.90 KMT2A (0.58) MEN1KMT2ANPC1RAB9ARXRA
SCHEMBL16775438 0.89 RXRA (0.52) MEN1KMT2ANPC1RAB9ARXRA
SCHEMBL16775437 0.89 RXRA (0.49) MEN1KMT2ANPC1RAB9ARXRA
SCHEMBL2710486 0.82 KMO (0.59) MEN1KMT2ANPC1RAB9ARXRA
SCHEMBL181903 0.81 MEN1 (0.53) MEN1KMT2ANPC1RAB9ARXRA
SCHEMBL2709784 0.81 RXRA (0.62) MEN1KMT2ANPC1RAB9ARXRA
SCHEMBL2710952 0.81 KMO (0.47) MEN1KMT2ANPC1RAB9ARXRA
SCHEMBL182067 0.81 KMO (0.47) MEN1KMT2ARXRARXRBKMO
SCHEMBL17125395 0.80 MEN1 (0.77) MEN1KMT2ANPC1RAB9ARXRA
SCHEMBL2707679 0.79 STIM1 (0.58) MEN1KMT2ANPC1RAB9AKMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9051342-B2 Pyrazole or triazole compounds and their use for the manufacture of a medicament for treating somatic mutation related diseases PTC THERAPEUTICS, INC. (US) 2015-06-09 US disclosed